Related Experiment Videos
Wegener granulomatosis in childhood: prolonged survival following cytotoxic therapy
The Journal of Pediatrics
|October 1, 1977
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Mutational analysis of the RPGRIP1L gene in patients with Joubert syndrome and nephronophthisis.
Kidney international·2007
The taurine transporter: mechanisms of regulation.
Acta physiologica (Oxford, England)·2006
Regulation of TauT by cisplatin in LLC-PK1 renal cells.
Pediatric nephrology (Berlin, Germany)·2005
Exercise Capacity, Muscle Mass, and Quality of Life in Pediatric Patients with Fontan Circulation.
The Journal of pediatrics·2026
Somatic Growth Faltering Precedes Brain Growth Deceleration in Preterm Infants: A Window for Intervention.
The Journal of pediatrics·2026
Life's Essential 8 Cardiovascular Health Characteristics in Children and Adolescents with Congenital Heart Disease.
The Journal of pediatrics·2026
Emergency Department Diagnosis of Concussion in Very Young Children with Head Injury.
The Journal of pediatrics·2026
Prenatal Exposure to Delta 9-Tetrahydrocannabinol and Child Neurodevelopment: A Critical Windows Analysis.
The Journal of pediatrics·2026
Time to Treatment Failure as a Recorded Treatment-Process Measure in C-CAT. Reply to Comment on "Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462".
Current oncology (Toronto, Ont.)·2026
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462.
Current oncology (Toronto, Ont.)·2026
[177Lu]Lu-PSMA-617 in Metastatic Hormone-Sensitive Prostate Cancer: Evidence from PSMAddition and Considerations for Treatment Sequencing.
Current oncology (Toronto, Ont.)·2026
A New Era of Treatment Sequencing in Platinum-Resistant Ovarian Cancer: Integrating Immunotherapy, Antibody-Drug Conjugates, and Targeted Therapies.
Current oncology (Toronto, Ont.)·2026